Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 50 and 80 years old
- French is your first/native language
- You are right-handed
- You have completed at least a primary school level of education
- You do not have any medical or mental health conditions that could affect your memory or thinking, apart from the conditions this trial is studying (see next point)
- You have been diagnosed with either "subjective cognitive decline" (where you feel your memory has gotten worse but tests appear normal) or "mild cognitive impairment" linked to early Alzheimer's disease (where some memory or thinking changes can be measured on tests) (confirm with trial site)
- You are covered by a French social security scheme
- You have been fully informed about the trial and have signed a consent form agreeing to take part
Who may not be able to join:
- You have a condition or device in your body that makes having an MRI scan unsafe, such as a pacemaker, cochlear implant, certain metal implants, recent joint replacements or bone devices, or you experience severe claustrophobia (fear of enclosed spaces)
- You have a hearing or vision problem that would interfere with the tests used in the trial
- You are currently pregnant or breastfeeding
- You are under any form of legal protection or guardianship, or are currently deprived of your liberty
- You have a score above 2 on a specific medical scale used to assess blood flow-related brain changes (confirm with trial site)
- You have been diagnosed with dementia
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pierre-Yves JONIN, PhD, Rennes University Hospital
Phone: 299284321
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Diffusion-MRI based parameters estimates of medial temporal lobe gray matter microstructure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.